Bank Of America Corp Age X Therapeutics, Inc. Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.33 - $0.74 $24 - $54	-74 Reduced 74.0%	26 $0
Q2 2023 Aug 14, 2023	SELL	$0.45 - $0.89 $45 - $89	-100 Reduced 50.0%	100 $0
Q1 2023 May 12, 2023	SELL	$0.56 - $0.8 $13 - $19	-24 Reduced 10.71%	200 $0
Q4 2022 Feb 10, 2023	BUY	$0.54 - $0.68 $12 - $16	24 Added 12.0%	224 $0
Q3 2022 Nov 14, 2022	SELL	$0.55 - $0.74 $550 - $740	-1,000 Reduced 83.33%	200 $0
Q1 2022 May 16, 2022	SELL	$0.65 - $1.2 $26 - $49	-41 Reduced 3.3%	1,200 $1,000
Q4 2021 Feb 08, 2022	BUY	$0.53 - $1.09 $21 - $44	41 Added 3.42%	1,241 $1,000
Q3 2021 Nov 15, 2021	SELL	$0.93 - $1.54 $132 - $218	-142 Reduced 10.58%	1,200 $1,000
Q2 2021 Sep 13, 2021	BUY	$1.14 - $1.77 $1,529 - $2,375	1,342 New	1,342 $2,000

Ticker AGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,945,100
Description
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.